Tandem Diabetes Care, Inc. (TNDM)
TNDMNASDAQ-GMMedical/Dental Instruments
$18.89
+0.1790 (+0.96%) today
Regular session, Nov 11, 1:01 PM ET
- Market cap
- $1.32bn
- P/E
- –
- EPS, last 4 quarters
- $-0.7200
- Dividend yield
- –
- Day range
- $18.65 to $19.76
- 52-week range
- $12.26 to $29.65
- Average volume
- 2.29m
- Previous close
- $18.71
Analysts
13 coveringHold7 buy, 6 hold, 0 sell
Targets a year out average $27.82, +47.3% from here
Earnings
next estimate $0.0800Next report
Dec 2025
+80.0%
Mar 2026
+34.8%
Jun 2026
+8.8%
Sep 2026
+63.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $290.38m | $247.22m | $254.56m | $283.69m |
| Gross profit | $167.46m | $136.79m | $144.78m | $160.42m |
| Operating income | $8.29m | -$17.43m | -$13.79m | -$2.37m |
| Net income | -$589.0k | -$20.39m | -$21.17m | -$7.08m |
Last four quarters: revenue $1.08bn, margin -4.6%, free cash flow -$36.30m
News
8 latest- What Tandem Diabetes Care (TNDM) Said on Its Q3 Earnings CallMarketBeat · 5 days ago
- Tandem (TNDM) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to SayZacks · 6 days ago
- Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Beats Revenue EstimatesZacks · 6 days ago
- PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue EstimatesZacks · 7 days ago
- Rapid Micro Biosystems, Inc. (RPID) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks · Oct 30, 2026
- Tandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks · Oct 29, 2026
- Is it the Right Time to Hold TNDM Stock in Your Portfolio?Zacks · Oct 9, 2026
The company
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company's pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- tandemdiabetes.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.